Quick Answer
Tevogen Bio Holdings Inc. reported Stockholders Equity of -$8.23 million for fiscal year 2025.
Tevogen Bio Holdings Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$8.23M | -23.4% |
| 2024 | -$6.67M | +92.9% |
| 2023 | -$94.43M | -178.1% |
| 2022 | -$33.95M | -138.6% |
| 2021 | -$14.23M | — |
| 2021 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.82M | -26.4% | +17.5% |
| June 30, 2025 | -$9.48M | -23.8% | -22.9% |
| March 31, 2025 | -$7.72M | -33.0% | -15.7% |
| December 31, 2024 | -$6.67M | +92.9% | -7.8% |
| September 30, 2024 | -$6.19M | +93.2% | +19.2% |
| June 30, 2024 | -$7.66M | +91.2% | -32.1% |
| March 31, 2024 | -$5.80M | +91.0% | +93.9% |
| December 31, 2023 | -$94.43M | -178.1% | -4.0% |
- Tevogen Bio Holdings Inc. showed a decrease of -23.4% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Tevogen Bio Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: